EUVIMEDEUVIMED entdecken
Crossref

FDA-approved polypeptide PTH 1–34 impedes palmitic acid-mediated osteoblasts dysfunction by promoting its differentiation and thereby improving skeletal health

Anirban Sardar, Divya Rai, Ashish Kumar Tripathi, Kunal Chutani, Shradha Sinha, Geeta Dhaniya, Ritu Trivedi

Molecular and Cellular Endocrinology · 2025

DOI: 10.1016/j.mce.2024.112445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2025. Verfasst von Anirban Sardar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, UP, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad…. Hauptthemen laut MEDLINE: Osteoblasts, Cell Differentiation, Palmitic Acid, Parathyroid Hormone. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, University Grants Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoblastsCell DifferentiationPalmitic AcidParathyroid HormoneBone and BonesAnimalsHumansMaleMice, Inbred C57BLAutophagyMiceApoptosisMitochondriaOsteogenesisCell SurvivalSignal TransductionMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

ApoptosisAutophagyDrug repurposingMitochondriaPeptideSaturated fatty acids

Substanzen

Palmitic AcidParathyroid Hormone

Autor:innen und Institutionen

  • Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, UP, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, UP, India.
  • Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, UP, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Electronic address: ritu_trivedi@cdri.res.in.

Förderung

  • Council of Scientific and Industrial Research, India
  • University Grants Commission

Zitieren

APA

Sardar, A., Rai, D., Tripathi, A. K., Chutani, K., Sinha, S., Dhaniya, G., & Trivedi, R. (2025). FDA-approved polypeptide PTH 1–34 impedes palmitic acid-mediated osteoblasts dysfunction by promoting its differentiation and thereby improving skeletal health. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112445

Vancouver

Sardar A, Rai D, Tripathi AK, Chutani K, Sinha S, Dhaniya G, et al. FDA-approved polypeptide PTH 1–34 impedes palmitic acid-mediated osteoblasts dysfunction by promoting its differentiation and thereby improving skeletal health. Molecular and Cellular Endocrinology. 2025. doi:10.1016/j.mce.2024.112445

BibTeX
@article{Sardar2025,
  author = {Sardar, Anirban and Rai, Divya and Tripathi, Ashish Kumar and Chutani, Kunal and Sinha, Shradha and Dhaniya, Geeta and Trivedi, Ritu},
  title = {FDA-approved polypeptide PTH 1–34 impedes palmitic acid-mediated osteoblasts dysfunction by promoting its differentiation and thereby improving skeletal health},
  journal = {Molecular and Cellular Endocrinology},
  year = {2025},
  doi = {10.1016/j.mce.2024.112445}
}
Kostenlos starten →